Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
130 hedge funds and large institutions have $648M invested in Arena Pharmaceuticals Inc in 2015 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 47 reducing their positions, and 12 closing their positions.
67% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 12
43% more call options, than puts
Call options by funds: $9.68M | Put options by funds: $6.75M
7% more funds holding
Funds holding: 122 → 130 (+8)
6% more capital invested
Capital invested by funds: $611M → $648M (+$37.4M)
26% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$7.64M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.11M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$4.2M |
| 4 |
Renaissance Technologies
New York
|
+$3.22M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$9.74M |
| 2 |
Millennium Management
New York
|
-$7.12M |
| 3 |
D.E. Shaw & Co
New York
|
-$3.87M |
| 4 |
TA
Teachers Advisors
New York
|
-$2.47M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.46M |
ARNA Hedge Fund Activity: Q2 2015 in Review
130 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2015, worth a combined $648M — up 6.1% from $611M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new ARNA positions and 12 closed out — a net gain of 8 holders — while 35 added to existing stakes and 47 trimmed.
The largest buyer was State Street, adding an estimated $7.64M. The largest seller was Deerfield Management, cutting an estimated $9.74M.
- 130 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2015, up from 122 in Q1 2015.
- Funds reported $648M of Arena Pharmaceuticals Inc stock for Q2 2015, up 6.1% quarter-over-quarter.
- 20 funds opened new Arena Pharmaceuticals Inc positions in Q2 2015 and 12 closed out, a net change of +8 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q2 2015 was State Street, an estimated $7.64M added.
- The largest Arena Pharmaceuticals Inc seller in Q2 2015 was Deerfield Management, an estimated $9.74M sold.
Based on aggregated 13F filings for Q2 2015.